ASK1 is a stress-activated MAP3K critical for apoptosis and inflammation regulation. Antibodies targeting ASK1 are widely used in cancer research and autoimmune disease studies.
ASK1 deletion reduces apoptosis in keratinocytes, promoting tumorigenesis in ASK2−/− mice .
Reduced ASK2 expression correlates with esophageal squamous cell carcinoma (ESCC) progression in humans .
ASK1 antibodies (e.g., CST #3762) detect endogenous ASK1 in WB with high specificity .
ADAM17 is a metalloprotease involved in EGFR ligand shedding and tumor progression. Inhibitory antibodies against ADAM17 show therapeutic potential in cancers like pancreatic ductal adenocarcinoma (PDAC).
A9(B8) IgG inhibits ADAM17 activity, delaying PDAC progression in preclinical models .
ADAM17 knockdown reduces motility in pancreatic cancer cells .
Anti-ADAM17 antibodies (e.g., A16782) show efficacy in immunofluorescence and IHC .
Parameter | ASK1 Antibody | ADAM17 Antibody |
---|---|---|
Primary Role | Apoptosis regulation, tumor suppression | EGFR ligand shedding, tumor promotion inhibition |
Key Diseases | Autoimmune disorders, cancer | Pancreatic cancer, inflammatory diseases |
Therapeutic Use | Investigational (e.g., ASK1 inhibitors in trials) | Preclinical (e.g., A9(B8) IgG for PDAC) |
Commercial Availability | Yes (CST #3762, R&D AF3575) | Yes (A16782, A9(B8) IgG) |
KEGG: ath:AT2G20160
STRING: 3702.AT2G20160.1
ASK17 (Uniprot accession: Q9SL65) is a member of the SKP1-like protein family in Arabidopsis thaliana. These proteins typically function as components of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes that play crucial roles in protein degradation via the ubiquitin-proteasome pathway. ASK17 participates in critical cellular processes including cell cycle regulation, hormone signaling, and stress responses. The protein contains approximately 160 amino acids and features a conserved SKP1-POZ domain essential for protein-protein interactions, particularly with F-box proteins .
ASK17 antibodies are valuable tools for multiple research applications:
Protein detection: Western blotting, immunoprecipitation, and ELISA for quantifying ASK17 expression levels
Protein localization: Immunohistochemistry (IHC) and immunofluorescence to determine subcellular and tissue distribution
Protein-protein interaction studies: Co-immunoprecipitation to identify binding partners
Chromatin immunoprecipitation (ChIP): When studying transcriptional regulatory roles
Flow cytometry: For cell-specific expression analysis
For immunohistochemical applications, researchers typically follow a protocol similar to that outlined for other plant proteins, involving paraffin-embedded sections, antigen retrieval, overnight primary antibody incubation at 4°C, and detection using peroxidase-conjugated secondary antibodies .
Researchers should assess ASK17 antibodies through:
Literature validation: Review published studies that have successfully employed the antibody
Positive and negative controls: Use tissues with known expression patterns and knockout lines
Western blot analysis: Confirm single band of appropriate molecular weight
Cross-reactivity testing: Evaluate potential recognition of other ASK family proteins
Multiple detection methods: Compare results across different techniques (Western blot, IHC, etc.)
Validation Method | Purpose | Expected Outcome for High-Quality ASK17 Antibody |
---|---|---|
Western blot | Specificity confirmation | Single band at ~18 kDa |
Immunohistochemistry | Localization pattern | Staining consistent with known expression |
Knockout control | Specificity verification | No signal in ASK17 knockout plants |
Peptide competition | Binding specificity | Signal abolished when pre-incubated with immunizing peptide |
Cross-reactivity analysis | Family specificity | Minimal recognition of other ASK proteins |
When selecting ASK17 antibodies, researchers should consider:
Antibody type: Polyclonal vs. monoclonal (polyclonals offer higher sensitivity but potentially lower specificity)
Host species: Choose based on compatibility with existing secondary antibodies and to avoid cross-reactivity
Immunogen design: Antibodies raised against unique epitopes of ASK17 minimize cross-reactivity with other ASK family members
Application validation: Ensure the antibody is validated for your specific application (WB, IHC, IP, etc.)
Lot-to-lot consistency: Consider requesting the same lot for extended studies to maintain consistency
For optimal ASK17 detection in plant tissues:
Fixation optimization: Test different fixatives (paraformaldehyde, glutaraldehyde) and durations to preserve protein structure while maintaining antigenicity
Antigen retrieval methods: Compare heat-induced (pressure cooker, microwave) versus enzymatic methods
Blocking optimization: Test different blocking agents (BSA, normal serum, commercial blockers) at various concentrations
Antibody titration: Establish optimal primary antibody dilutions (typically 1:100-1:1000)
Signal amplification: Consider tyramide signal amplification for low-abundance targets
Following a methodology similar to that described for other antibodies, researchers should evaluate staining intensity on a scale of 0-3 (negative to high) and assess the extent of staining as a percentage of positively stained cells (0-3 for 0%, 1-25%, 26-50%, and 51-100%) .
Advanced validation approaches include:
Genetic validation: Test antibody in ASK17 knockout/knockdown lines (T-DNA insertion lines, CRISPR-Cas9 edited plants)
Recombinant protein controls: Use purified ASK17 protein as positive control
Epitope mapping: Identify the specific binding region to predict potential cross-reactivity
Mass spectrometry validation: Confirm identity of immunoprecipitated proteins
Bioinformatic analysis: Compare epitope sequence conservation across ASK family
This multi-faceted validation approach resembles methods used for other antibodies in research contexts, where specificity is critical for accurate interpretation of results .
Recent advances in computational biology offer powerful tools for enhancing antibody specificity:
Binding mode identification: Computational models can identify distinct binding modes associated with specific ligands, allowing prediction of antibody variants with customized specificity profiles
Epitope prediction: In silico analysis of ASK17 structure to identify unique surface-exposed regions
Cross-reactivity prediction: Identify sequence homology with other ASK family members to avoid targeting conserved regions
Structure-based optimization: Use protein structure modeling to refine antibody design
Biophysics-informed models trained on experimental data can be particularly valuable, enabling prediction and generation of specific variants beyond those observed in experiments .
For multiplex protocols involving ASK17:
Antibody compatibility: Select primary antibodies from different host species to avoid cross-reactivity
Sequential staining: Consider sequential rather than simultaneous application when using multiple antibodies
Spectral overlap: Choose fluorophores with minimal spectral overlap for immunofluorescence
Signal-to-noise optimization: Balance sensitivity and background through careful titration
Controls: Include single-stain controls to verify specificity in the multiplex context
Inconsistent staining may be addressed through:
Fixation optimization: Test different fixation protocols to preserve epitope accessibility
Antigen retrieval adjustment: Modify pH, buffer composition, or duration of antigen retrieval
Tissue permeabilization: Optimize detergent concentration and incubation time
Antibody concentration titration: Test serial dilutions to identify optimal concentration
Incubation conditions: Adjust temperature, time, and buffer composition
Researchers might apply systematic troubleshooting approaches similar to those used for other antibodies, where staining intensity is evaluated across multiple experimental conditions .
When facing contradictory results:
Epitope mapping: Determine if different antibodies recognize distinct epitopes on ASK17
Validation in knockouts: Test all antibodies in ASK17 knockout lines
Orthogonal methods: Verify results using non-antibody methods (e.g., mRNA expression)
Cross-reactivity assessment: Evaluate each antibody for recognition of other ASK family members
Post-translational modification sensitivity: Determine if results differ due to sensitivity to protein modifications
This approach parallels methods used to resolve contradictions with other antibodies in research settings .
For rigorous quantification:
Standard curves: Use recombinant ASK17 protein to generate standard curves for absolute quantification
Normalization controls: Include loading controls (housekeeping proteins) for relative quantification
Technical replicates: Perform at least three technical replicates per biological sample
Quantitative image analysis: Use appropriate software for densitometry or fluorescence intensity measurement
Statistical validation: Apply appropriate statistical tests to determine significance of observed differences
To distinguish specific from non-specific binding:
Competitive inhibition: Pre-incubate antibody with immunizing peptide
Knockout controls: Compare staining in wildtype versus ASK17 knockout tissues
Isotype controls: Use non-specific antibodies of the same isotype and concentration
Cross-adsorption: Pre-adsorb antibody with related proteins to remove cross-reactive antibodies
Titration analysis: Examine dose-dependent binding patterns
Advanced systems biology applications include:
Protein interactome mapping: Identify all ASK17 binding partners through IP-MS
Spatiotemporal expression profiling: Map ASK17 expression across developmental stages and stress conditions
Post-translational modification mapping: Identify how modifications regulate ASK17 function
Network modeling: Integrate ASK17 data into computational models of plant signaling networks
Single-cell analysis: Examine cell-type specific expression patterns
These approaches leverage antibody-based methods to generate comprehensive datasets for systems-level understanding of ASK17 function.
Cutting-edge technologies include:
Machine learning-based antibody design: Computational prediction of optimal epitopes and binding characteristics
Single-domain antibodies: Smaller antibody fragments with enhanced tissue penetration
Proximity ligation assays: Detecting protein interactions with greatly enhanced sensitivity
Super-resolution microscopy: Nanoscale localization of ASK17 within cellular compartments
Biophysics-informed modeling: Identifying multiple binding modes to design antibodies with customized specificity profiles
Advanced computational approaches include:
Sequence-based epitope prediction: Identifying unique regions of ASK17 as antibody targets
Structural modeling: Predicting antibody-antigen interaction based on 3D structures
Biophysics-informed models: Training models on experimental data to predict novel antibody variants with desired specificity
Multiple binding mode analysis: Identifying distinct binding modes associated with specific ligands
Cross-reactivity prediction: Computational screening for potential off-target binding
Recent advances demonstrate that "biophysics-informed models trained on experimental data can predict and generate specific variants beyond those observed in experiments," suggesting potential applications for designing ASK17 antibodies with customized specificity profiles .
Investigating ASK17 in stress responses:
Stress-induced expression changes: Use antibodies to quantify ASK17 protein levels under various stresses
Post-translational modifications: Develop modification-specific antibodies to track regulatory changes
Protein-protein interaction dynamics: Apply co-IP to identify stress-specific binding partners
Subcellular relocalization: Track ASK17 movement during stress responses
Tissue-specific expression: Map expression patterns across tissues during stress adaptation
When comparing ASK family antibodies:
Epitope conservation: Assess degree of sequence similarity at antibody binding sites
Cross-reactivity profiles: Systematically test each antibody against all ASK family members
Performance metrics: Compare sensitivity, specificity, and signal-to-noise ratios
Application versatility: Evaluate performance across different experimental techniques
Reproducibility: Compare lot-to-lot variation between different ASK antibodies
ASK Family Member | Uniprot ID | Molecular Weight | Key Distinguishing Features |
---|---|---|---|
ASK17 | Q9SL65 | ~18 kDa | Specific to Arabidopsis thaliana |
ASK15 | Q1PEL7 | ~18 kDa | 76% sequence identity with ASK17 |
ASK19 | O81058 | ~19 kDa | 65% sequence identity with ASK17 |
ASK11 | O49484 | ~18 kDa | Different tissue expression pattern |
ASK7 | Q9LSY0 | ~18 kDa | Distinct F-box protein binding profile |
Lessons from other plant protein antibodies:
Epitope selection strategies: Identify most successful approaches for plant-specific antigens
Validation methodologies: Adapt rigorous validation frameworks from other fields
Production systems: Compare efficacy of different expression systems for plant protein antigens
Application optimization: Adapt protocols developed for other challenging plant targets
Cross-species reactivity: Evaluate conservation of epitopes across plant species for broader utility
Researchers can apply biophysics-informed models similar to those described for other antibodies, identifying distinct binding modes to design ASK17 antibodies with improved specificity and reduced cross-reactivity .